Is there a role for post-operative chemoradiation therapy in fully resected, margin-negative T3N1 NSCLC?

I assume you're talking about T3 for chest wall invasion, and I think the answer is probably no routine role for RT for this individual risk factor. If you look at surgical series, invasion of the chest wall IS a risk factor for both positive surgical margins, and local recurrence. But if you limit ...

I agree with @Dr. First Last.

While survival in resected lung cancer is dominently driven by nodal status, the utility of PORT is murky.

The principal issue appears to be a tradeoff between the appealing feature of RT in reducing local-regional recurrence, contrasted with the rather compelling data th...